MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Triple Helix Cluster & Developments: California
Metropolitan Areas: California
Industry: Silicon Valley, California
Vaxcyte, Inc. (NASDAQ: PCVX)*
Organization & Developments: Vaxcyte
Parents
Vaxcyte, Inc. (NASDAQ: PCVX)*
Children
*Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine.
*The company also develops VAX-XP to protect against emerging strains causing significant invasive pneumococcal disease and antibiotic resistance
*The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020
*VAX-A1, a conjugate vaccine candidate for protection against subtypes of Group A Strep
*VAX-PG, a novel protein vaccine candidate targeting porphyromonas gingivalis.
*Vaxcyte, Inc., a preclinical-stage biotechnology vaccine company, develops vaccines to prevent or treat infectious diseases worldwide.
2022: Vaxcyte Has A Bright Future Ahead_ seekingalpha.com
2023: Vaxcyte: End Of Phase 2 Meeting FDA Q4 Of 2023 To Get Ball Rolling
2023: Vaxcyte: Looking Fully Valued_ seekingalpha.com
2024: A plucky biotech threatening Pfizer’s grip on the Prevnar vaccine market
2024: Vaxcyte, Inc. 2023 Q4 - Results - Earnings Call Presentation
2025: Vaxcyte Aims To Outshine Pfizer With Bold VAX-31 Strategy_ seekingalpha.com
2025: Vaxcyte: Sentiment Is Pushing The Shares Down
Jumps
Finance & Acquisitions: Vaxcyte
Key People: Vaxcyte